NO20003217D0 - Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)- sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre - Google Patents

Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)- sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre

Info

Publication number
NO20003217D0
NO20003217D0 NO20003217A NO20003217A NO20003217D0 NO 20003217 D0 NO20003217 D0 NO 20003217D0 NO 20003217 A NO20003217 A NO 20003217A NO 20003217 A NO20003217 A NO 20003217A NO 20003217 D0 NO20003217 D0 NO 20003217D0
Authority
NO
Norway
Prior art keywords
carbazole
fluorophenyl
tetrahydro
sulfonyl
amino
Prior art date
Application number
NO20003217A
Other languages
English (en)
Other versions
NO316618B1 (no
NO20003217L (no
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of NO20003217L publication Critical patent/NO20003217L/no
Publication of NO20003217D0 publication Critical patent/NO20003217D0/no
Publication of NO316618B1 publication Critical patent/NO316618B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20003217A 1997-12-24 2000-06-21 Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre (Ramatroban), samt fremgangsmåte og anvendelse derav NO316618B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
PCT/JP1998/005844 WO1999033803A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Publications (3)

Publication Number Publication Date
NO20003217L NO20003217L (no) 2000-06-21
NO20003217D0 true NO20003217D0 (no) 2000-06-21
NO316618B1 NO316618B1 (no) 2004-03-08

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003217A NO316618B1 (no) 1997-12-24 2000-06-21 Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre (Ramatroban), samt fremgangsmåte og anvendelse derav

Country Status (37)

Country Link
US (1) US6362214B1 (no)
EP (1) EP1051398B1 (no)
JP (2) JP3817668B2 (no)
KR (1) KR100586350B1 (no)
CN (1) CN1140510C (no)
AR (1) AR013803A1 (no)
AT (1) ATE263152T1 (no)
AU (1) AU744242B2 (no)
BG (1) BG65024B1 (no)
BR (1) BR9814496A (no)
CA (1) CA2313230A1 (no)
CO (1) CO4970800A1 (no)
DE (2) DE19757983A1 (no)
DK (1) DK1051398T3 (no)
ES (1) ES2218874T3 (no)
GT (1) GT199800198A (no)
HK (1) HK1034517A1 (no)
HN (1) HN1998000186A (no)
HU (1) HUP0004432A3 (no)
ID (1) ID25446A (no)
IL (1) IL136278A (no)
IN (1) IN192932B (no)
MY (1) MY116312A (no)
NO (1) NO316618B1 (no)
NZ (1) NZ504741A (no)
PE (1) PE20000115A1 (no)
PL (1) PL341359A1 (no)
PT (1) PT1051398E (no)
RU (1) RU2220137C2 (no)
SI (1) SI1051398T1 (no)
SK (1) SK285109B6 (no)
TR (1) TR200001936T2 (no)
TW (1) TW552258B (no)
UA (1) UA66832C2 (no)
UY (2) UY25324A1 (no)
WO (1) WO1999033803A1 (no)
ZA (1) ZA9811817B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395120T3 (es) * 2006-12-20 2013-02-08 Cardoz Ab Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios
CA2675520A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
BR9814496A (pt) 2000-10-10
WO1999033803A1 (en) 1999-07-08
RU2220137C2 (ru) 2003-12-27
DE69822882D1 (en) 2004-05-06
ID25446A (id) 2000-10-05
SI1051398T1 (en) 2004-08-31
US6362214B1 (en) 2002-03-26
PT1051398E (pt) 2004-07-30
AR013803A1 (es) 2001-01-10
NZ504741A (en) 2002-10-25
AU1687499A (en) 1999-07-19
NO316618B1 (no) 2004-03-08
KR100586350B1 (ko) 2006-06-07
DE19757983A1 (de) 1999-07-01
CA2313230A1 (en) 1999-07-08
IL136278A0 (en) 2001-05-20
HUP0004432A2 (hu) 2001-06-28
JP4411269B2 (ja) 2010-02-10
BG65024B1 (bg) 2006-12-29
JP2001527067A (ja) 2001-12-25
CO4970800A1 (es) 2000-11-07
TW552258B (en) 2003-09-11
AU744242B2 (en) 2002-02-21
HK1034517A1 (en) 2001-10-26
ATE263152T1 (de) 2004-04-15
SK9752000A3 (en) 2001-02-12
KR20010033529A (ko) 2001-04-25
ES2218874T3 (es) 2004-11-16
DK1051398T3 (da) 2004-07-19
MY116312A (en) 2003-12-31
IN192932B (no) 2004-06-12
JP3817668B2 (ja) 2006-09-06
SK285109B6 (sk) 2006-06-01
CN1282320A (zh) 2001-01-31
DE69822882T2 (de) 2005-02-03
TR200001936T2 (tr) 2001-01-22
HUP0004432A3 (en) 2002-10-28
NO20003217L (no) 2000-06-21
IL136278A (en) 2005-03-20
JP2006151977A (ja) 2006-06-15
PE20000115A1 (es) 2000-03-26
UY25324A1 (es) 2000-12-29
UA66832C2 (uk) 2004-06-15
EP1051398B1 (en) 2004-03-31
CN1140510C (zh) 2004-03-03
UY25575A1 (es) 1999-11-17
ZA9811817B (en) 1999-06-29
BG104554A (en) 2001-05-31
GT199800198A (es) 1998-12-15
PL341359A1 (en) 2001-04-09
HN1998000186A (es) 1999-11-03
EP1051398A1 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
NO990059D0 (no) Analoger av kationiske proteiner
HUP9902136A3 (en) Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
FI973085A0 (fi) Menetelmä 1-(tiometyyli)syklopropaanietikkahapon valmistamiseksi
AU3214897A (en) Encapsulation of proprietary protocol information
AU5474996A (en) Novel crystalline forms of anhydrous 7-{(1alpha,5alpha, 6alpha)-6-amino-3-azabicyclo(3.1.0)hex-3-y1}-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid, methanesulfonic acid salt.
AU7232298A (en) Surgical instrument for the transplantation of self-grown hair
IT1301931B1 (it) Collegamento d'alberi
NO20003217D0 (no) Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)- sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
DE69814346D1 (de) Herstellung von phosphatestern
ZA975755B (en) Useful formulations of acid addition salt drugs.
BR9706942A (pt) Método de transformação genética de árvores
ATE227733T1 (de) Herstellung von avermectin-verbindungen
NO995619D0 (no) Kjemisk fremgangsmåte for fremstilling av 1-substituerte 3-hydroksymetyl-4-(4-fluorfenyl)tetrahydropyridiner
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
PT1133495E (pt) Semi-hidrocloreto do acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|-nonano-8-il)-6-fluoro-1,4-diidro-4-oxo-3-quinolinocarboxilico
NO981499L (no) FremgangsmÕte for fremstilling av titandioksyd
AU8985298A (en) Novel sulphonamide derived from substituted anilines useful as medicines
DE69822338D1 (de) Polyisobuten substituierte bernsteinsäureimide
HUP9800430A3 (en) Novel benzenesulfonamide derivatives, process for preparing them and pharmaceutical compositions containing them
AU2178999A (en) Preparation of methacrylic acid, derivatives thereof or precursors thereto
ITRM970049A1 (it) Procedimento per la preparazione dell'acido 2-iodossibenzoico.
IT1291675B1 (it) Procedimento per la preparazione dell'acido 4,5-difenilossazol-2- propanoico
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide